Skip to content
Home
About Us
Clinical Trials
Science & Technology
Pipeline
Investor Relations
Resources
Patient Resources
Contact
Coya Therapeutics’ COYA 303 Shows Promising Central Nervous System (CNS) Anti-inflammatory Effects and Systemic Regulatory T Cell (Treg) Enhancing Effects in a Preclinical Animal Inflammation Model
September 16, 2025
Share this post